C
innamon is one of the most commonly used spices worldwide next to black pepper. It is prepared from the dried inner bark of evergreen trees grown in South Asia (Ceylon cinnamon, Cinnamomum zeylanicum) and Southeast Asia (Chinese cinnamon or cassia, Cinnamomum cassium). References to it date back to antiquity, being mentioned in several books of the Bible and in the histories of ancient Rome and Egypt as well as medieval Europe. Its historical uses were quite varied and included applications for flavoring, food preservation, and medicines and even as an embalming agent. Currently, cinnamon has primary uses in foods and fragrances. In foods, it is noted for conveying a sense of sweetness and warmth and is found as a flavoring agent in diverse products such as baked goods, beverages, meat dishes, cereals, and fruit preparations. Oil from the bark is also used in the manufacture of perfumes, cosmetics, shampoos, and toilet soaps. The purported health benefits from cinnamon have been linked to a variety of constituents. A brief summary of potential health benefits, evaluation of the quality of the scientific research, and suggestions for future research are presented below.
Summary
The scientific literature provides emerging evidence that cinnamon may have health benefits, particularly in improving problematic blood glucose regulation that is a consequence of type 2 diabetes and obesity. There is suggestive evidence that cinnamon may improve blood cholesterol concentrations in humans and lower blood pressure in rats. Preliminary evidence in cell culture studies suggests that cinnamon contains antioxidant constituents and possesses anti-inflammatory and antimicrobial properties. An overview of major uses for cinnamon is presented in Table 1 , and the strength of the evidence is graded. Points of view or ratings for the strength of the scientific evidence are based on consideration of cell culture and animal and human clinical data from the peer-reviewed scientific literature. Greater strength of evidence was given when there were both preclinical and clinical data, and there was consistency of findings among well-controlled human studies.
The chemical composition of cinnamon has been characterized, with cinnamaldehyde (cinnamic aldehyde, 3-phenyl-2-propenal) being identified as the major constituent from the bark and eugenol (2-methoxy-4-(2 propenyl)phenol) as the primary component in extracts from the leaf. Other constituents in cinnamon include cinnamyl alcohol, coumarin, phenolic acids, terpenes, carbohydrates, and tannins. Cinnamaldehyde, also found in blueberries and cranberries, is generally recognized as safe (GRAS) for use as a flavoring by the Flavoring Extract Manufacturers Association and is approved for food use by the Food and Drug Administration (21 CFR 182.60). There are limited reports of cinnamaldehyde as a skin allergen when used in fragrances and toothpastes.
1Y3 Such cases are uncommon, however, and there currently are no safety concerns for its use in fragrances and cosmetics. 4 Cinnamaldehyde as a principal constituent of cinnamon has also been evaluated individually for health benefits similar to those outlined above and is purported to have, based on cell culture and animal studies, antimicrobial, antioxidative, anti-inflammatory, and anticancer actions.
Conclusions
Based on the current scientific evidence, more information is needed on the health benefits of cinnamonV particularly in human subjects. There is suggestive evidence from human studies that cinnamon can lower blood glucose and modulate insulin levels associated with type 2 diabetes. However, the database for using cinnamon in the treatment of diabetes is fairly weak and not yet conclusive. It would be of considerable value to further confirm the benefits of cinnamon intake in improving glucose tolerance and insulin sensitivity on people without diabetes. Evidence that cinnamon also lowers diabetes-associated blood cholesterol and lipid concentrations is inconsistent and inconclusive. Table 2 provides a summary of select trials of cinnamon on diabetes end points.
Cinnamon intakes used in human studies are considerably greater than levels usually consumed as part of a typical diet, with amounts ranging from about 1 to 6 g/d for periods of time varying in length Antidiabetic agent E Preclinical animal studies provide evidence that constituents of cinnamon may decrease blood glucose and insulin levels both in rats genetically predisposed to diabetes and in rats given high doses of sugars.
5Y8
Evidence for an antidiabetic action of cinnamon components in humans is inconsistent but suggestive of a possible modest action in lowering blood glucose levels ( Table 2) . 1,9Y20 It should be noted that in 2 studies, cinnamon ingestion improved in vivo glucose tolerance in healthy human subjects. 15, 16 Specific constituents of cinnamon responsible for any antidiabetic effect remain to be identified.
21Y23
Several agents such as cinnamaldehyde and polyphenolic polymers have been proposed as putative active factors. A meta-analysis and 3 recent reviews have evaluated the evidence for this potential health benefit. 1, 17, 19, 20 This antidiabetic action of cinnamon clearly warrants further study, and the basis for inconsistencies among studies needs to be resolved. Cholesterol-lowering actions P Human trials of cinnamon extract do not consistently demonstrate a benefit in lowering diabetes-associated blood cholesterol levels or improving blood lipid profiles.
9Y11, 19, 20 Blood pressureYlowering effect P Cinnamon lowered sugar-induced blood pressure increase in one study of rats predisposed to hypertension. 24 Further study of this action of cinnamon is needed. Anti-inflammatory and antioxidant effects P Antioxidant components of cinnamon have been identified. There are several reports using cell culture models and an experiment in rats demonstrating that cinnamon and cinnamaldehyde have antioxidant activity and scavenge free radicals. 20 ,25Y27 There is very limited evidence that cinnamon and cinnamaldehyde have immunomodulatory properties and can suppress inflammation processes. 20, 28, 29 There are few reports of cinnamon being effective as an antioxidant or anti-inflammatory agent in humans. 20 Antimicrobial properties P There are a number of reports in cell culture studies indicating that cinnamon can inhibit the growth of bacteria associated with food contamination and human infections. 20, 27 There is a lack of evidence of an antimicrobial benefit in humans. One trial evaluated cinnamon for its capacity to inhibit the bacterium associated with stomach ulcers and demonstrated no benefit. 30 Anticancer actions P There is very limited scientific information pointing to a cancer-protective benefit of cinnamon components. 20,31,32 a Rating: S, strong, convincing evidence; E, emerging, suggestive evidence; P, preliminary, inconclusive evidence.
Food and Nutrition Cinnamon and Health from 6 weeks to 4 months. More evidence from well-designed clinical trials is needed, especially those that examine cinnamon doses relevant to typical intakes. Particularly important will be a better characterization of the possible contributors to variation in cinnamon's effects, such as those due to diet, sex, ethnicity, body mass index, fasting blood glucose levels, and use of other medications. 12, 19, 20 There is little research on cinnamon's antioxidant action in humans. There is suggestive evidence that cinnamon can provide such benefits in animals. Cinnamon antioxidant activity has been demonstrated in multiple cell culture studies. However, it is not known whether these constituents are bioavailable in humans once ingested. This question needs to be further explored.
An animal study indicates that cinnamon may lower sugar-induced blood pressure. Furthermore, research suggests that cinnamon contains constituents that have anti-inflammatory and antimicrobial properties. Additional investigations of these potential health benefits in animals and in human trials are needed. 
